Related Experiment Video

Updated: May 30, 2026

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
09:40

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

Downregulation of CDKN2A and suppression of cyclin D1 gene expressions in malignant gliomas

Weidong Liu1, Guohua Lv, Yawei Li

  • 1Department of Spinal Surgery, Second Xiangya Hospital, Central South University, 139 RenMin Road, Changsha, China.

Journal of Experimental & Clinical Cancer Research : CR
|August 17, 2011
PubMed
Abstract

Insights

CDKN2A acts as a tumor suppressor gene in malignant gliomas. Lower CDKN2A expression correlates with high-grade gliomas, suggesting its potential as a prognostic marker and therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Malignant gliomas are the most prevalent central nervous system cancers.
  • The CDKN2A gene is a known susceptibility locus for glioma.
  • The CDKN2A/cyclin-dependent kinase 4, 6/Retinoblastoma protein (Rb) pathway is implicated in glioma pathogenesis.

Purpose of the Study:

  • Investigate CDKN2A expression in relation to glioma grade.
  • Elucidate the role of CDKN2A in malignant glioma development.

Main Methods:

  • Immunohistochemical staining and western blot analysis of CDKN2A in 61 glioma samples.
  • In vitro studies involving overexpression and knockdown of CDKN2A in human glioma cell lines.
  • Assessment of cell proliferation, colony formation, and the CDKN2A-Cyclin-Rb pathway.

Main Results:

  • Lower CDKN2A expression and higher cyclin D1 expression were observed in high-grade gliomas compared to low-grade gliomas.
  • Overexpression of CDKN2A suppressed glioma cell line growth by inhibiting cyclin D1 gene expression.

Conclusions:

  • CDKN2A functions as a tumor suppressor gene in malignant gliomas.
  • CDKN2A may serve as a predictive biomarker for high-grade glioma behavior.
  • Targeting the CDKN2A-Cyclin-Rb pathway holds potential for malignant glioma treatment.

More Related Videos

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells12:52

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Published on: November 28, 2015

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.